Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder

Inflammatory Bowel Diseases

Volumn 7, Issue 2, 2001, Pages 136-145

  Dunne, Colum ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Gastrointestinal ecosystem; Gut disorders; Microflora; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; BACTERIUM; BIOTECHNOLOGY; CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DOUBLE BLIND PROCEDURE; ECOLOGY; ECOSYSTEM; ENTERITIS; ENTEROPATHY; FOOD ALLERGY; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; HOST; HUMAN; IMMUNOMODULATION; INTESTINE ADAPTATION; IRRITABLE COLON; MEDICAL RESEARCH; MICROBIOLOGY; MICROORGANISM; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; ULCERATIVE COLITIS;

EID: 0034782712     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200105000-00010     Document Type: Review

References (172)

1. Probiotics: Functionality and commercial status
2. Human fecal flora: The normal flora of 20 Japanese-Hawaiians
3. Microbial ecology of the gastrointestinal tract
4. Microbial ecology of the human large intestine
5. Probiotic properties of lactic-acid bacteria: Plenty of scope for fundamental R & D
6. Protection against gastrointestinal diseases-present facts and future developments
7. Probiotics in the new millennium
8. The indigenous gastrointestinal microflora
9. Developmental microbial ecology of the neonatal gastrointestinal tract
10. Analyzing the molecular foundations of commensalism in the mouse intestine
11. The intestinal immune system
12. Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology
13. Colonic microflora: Nutrition and health
14. In situ bacterial metabolism and colon mutagens
15. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics
16. Short chain fatty acids in the human colon
17. In vivo and in vitro models of the human colonic flora
18. Probiotics, prebiotics and human gut microbiology
19. Functional food science and gastrointestinal physiology and function
20. The control and consequences of bacterial fermentation in the human colon
21. Role of intestinal bacteria in nutrient metabolism
22. Carbohydrate fermentation, energy transduction and gas metabolism in the human intestine
23. Metabolic epidemiology of colon cancer: Enzymic activity of fecal flora
24. The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds
25. Proteolysis and amino acid fermentation
26. Dietary modulation of intestinal bacterial infections
27. Overview of gut flora and probiotics
28. Acid reduction and recurrent enteritis
29. Translocation of enteric bacteria in humans
30. Bacterial translocation: The influence of dietary variables
31. 2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection
32. Host-microbe interaction in the gastrointestinal tract
33. Indigenous, normal and autochthonous flora of the gastrointestinal tract
34. Intestinal bacteria and disease
35. Analysis of the intestinal microflora: A renaissance
36. Lactobacillus bacteraemia and endocarditis: Review of 45 cases
37. Safety of industrial lactic acid bacteria
38. Influences of microbiota on intestinal immune system development
39. Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms
40. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut
41. Microbial colonization influences composition and T-cell receptor V beta repertoire of intraepithelial lymphocytes in rat intestine
42. Development and maintenance of the gut-associated lymphoid tissue (GALT): The roles of enteric bacteria and viruses
43. Double blind, placebo controlled trial of metronidazole in Crohn's disease
44. Is there a role for antibiotics as primary therapy in Crohn's ileitis?
45. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease
46. The case for an infective etiology
47. Current concepts of the etiology and pathogenesis of Crohn's disease and ulcerative colitis
48. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
49. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
50. Microbial factors in chronic intestinal inflammation
51. The influence of normal microbial flora on the development of chronic mucosal inflammation
52. Aberrant host immune responses to luminal bacteria in the pathogenesis of chronic inflammatory bowel disease
53. Interactions between commensal bacteria and mucosal immunocompetent cells
54. The intestinal microflora and inflammatory bowel disease
55. Ulcerative colitis and E. coli with adhesive properties
56. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique
57. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens
58. Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives
59. Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis
60. 2 microglobulin transgenic rats
61. T cell receptor αβ-deficient mice fail to develop colitis in the absence of a microbial environment
62. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL2-deficient mice
63. Animal models of intestinal inflammation: New insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease
64. Irritable bowel syndrome-post salmonella infection
65. The immunomodulation of enteric neuromuscular function: Implications for motility and inflammatory disorders
66. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome
67. Stress, inflammation and the irritable bowel syndrome
68. Role of human microflora in health and disease
69. The gut and its micro-organisms
70. Neglected niches: The microbial ecology of the gastrointestinal tract
71. Gastrointestinal microflora in mammalian nutrition
72. Upper gastrointestinal tract disease and probiotics
73. Microbial evaluation of jejunal aspirates and faecal samples after oral administration of bifidobacteria and lactic acid bacteria
74. Probiotic spectra of Lactic Acid bacteria (LAB)
75. The normal colonic bacterial flora
76. Human faecal flora: Variations in bacterial composition within individuals and a possible effect of emotional stress
77. Normal indigenous intestinal flora
78. The gastrointestinal microflora and fermented milks
79. Role of intestinal flora in health with special reference to dietary control of intestinal flora
80. Intestinal flora and ageing
81. The incidence of pathogenic organisms in the normal flora of the neonate's external ear and nasopharynx
82. The origin of O serotypes of Escherichia coli in babies after normal delivery
83. Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: A prospective study
84. Colonization of caesarean section babies by Escherichia coli
85. Escherichia coli isolated from babies delivered by caesarean section and their environment
86. The piglet as a model animal for studying aspects of digestion and absorption in milk-fed human infants
87. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life
88. The fate and effects of transiting, non-pathogenic microorganisms in the human intestine
89. Intestinal flora of infants
90. Development of intestinal microbiota
91. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria
92. 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community
93. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples
94. Human colonic biota studied by ribosomal DNA sequence analysis
95. Methods for the analysis of the intestinal microflora
96. The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME)
97. Survival of a probiotic, Lactobacillus casei Shirota, in the gastrointestinal tract: Selective isolation from faeces and identification using monoclonal antibodies
98. In vivo assessment of potential probiotic Lactobacillus salivarius strains: Evaluation of their establishment, persistence, and localisation in the murine gastrointestinal tract
99. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations
100. Molecular microbial ecology: A mini-review
101. Combination of fluorescent in situ hybridization and microautoradiography-A new tool for structure-function analyses in microbial ecology
102. Automated confocal laser scanning microscopy and semiautomated image processing for analysis of biofilms
103. Development and validation of an automated, microscopy-based method for enumeration of groups of intestinal bacteria
104. Partial and complete 16S rRNA sequences, their use in generation of 16S phylogenetic trees and their implications in molecular ecology studies
105. Phylogenetic identification and in situ detection of individual microbial cells without cultivation
106. A molecular view of the intestinal ecosystem
107. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA
108. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology
109. Quantification of 16S rRNAs in complex bacterial communities by multiple competitive reverse transcription-PCR in temperature gradient gel electrophoresis fingerprints
110. Strategies for isolation of in vivo expressed genes from bacteria
111. A review: Probiotics in man and animals
112. Probiotics
113. Studies of the intestinal microflora: A prerequisite for the development of probiotics
114. Review of probiotics available to modify gastrointestinal flora
115. Probiotics and prebiotics: Can regulating the activities of intestinal flora benefit health?
116. Bioactive proteins and probiotic bacteria: Modulators of nutritional health
117. Stimulation of the immune system by lactic cultures
118. The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease
119. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers
120. Lactobacillus GG-a human probiotic strain with thorough clinical documentation
121. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans
122. Demonstration of safety of probiotics-a review
123. An overview of probiotics, prebiotics and synbiotics in the functional food concept: Perspectives and future strategies
124. Ingredient selection criteria for probiotic micro-organisms in functional dairy products
125. Selection of probiotic strains for human applications
126. Lactic acid bacteria with health claims-interactions and interference with gastrointestinal flora
127. The scientific basis for probiotic strains of Lactobacillus
128. Taxonomy and physiology of probiotic lactic acid bacteria
129. Overview of functional foods: Emphasis on probiotic bacteria
130. Bifidobacterium spp. and Lactobacillus acidophilus: Biological, biochemical, technological and therapeutical properties relevant for use as probiotics
131. The technology of probiotics
132. Probiotics, prebiotics or "conbiotics"
133. Probiotic bacteria: Myth or reality?
134. The biotechnology of lactic acid bacteria with emphasis on applications in food safety and human health
135. Probiotics: Mechanisms and established effects
136. Probiotics: From myth to reality-demonstration of functionality in animal models of disease and in human clinical trials
137. In vitro selection criteria for human probiotic strains-correlation with in vivo findings
138. Enteral feeding of premature infants with Lactobacillus GG
139. Effect of administration of Lactobacillus casei strain GG on the gastrointestinal microbiota of newborns
140. A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhea in children
141. Potential of using lactic acid bacteria for therapy and immunomodulation in man
142. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges
143. The development of functional foods: Lessons from the gut
144. Effect of oral administration of freeze-dried Lactobacillus acidophilus on small bowel bacterial overgrowth in patients with end stage kidney disease: Reducing uremic toxins and improving nutrition
145. The role of probiotic bacteria in cancer prevention
146. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
147. A placebo controlled trial of Lactobacillus GG to prevent diarrhoea in undernourished Peruvian children
148. Lactobacilli to prevent traveller's diarrhoea
149. Saccharomyces boulardii for Clostridium difficile associated enteropathies in infants
150. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin
151. Treatment of Clostridium difficile diarrhoea with brewer's yeast
152. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG
153. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders
154. Interleukin-10 deficient mice development chronic enterocolitis
155. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat
156. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
157. high T cells to SCID recipients
158. + T cells
159. Fecal B-D-Galactosidase production and bifidobacteria are decreased in Crohn's disease
160. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects?
161. Standards for trials of therapy in inflammatory bowel disease
162. Design of treatment trials for functional gastrointestinal disorders
163. Protection from gastrointestinal diseases with the use of probiotics
164. Probiotics: Towards demonstrating efficacy
165. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
166. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study
167. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
168. Modulation of non-specific mechanisms of defense by lactic acid bacteria: Effective dose
169. Modulation of humoral immune response through probiotic intake
170. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains
171. Potential hazards of probiotic bacteria for immunodeficient patients
172. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus